Risperidone Does Not Induce Menstrual Periods—It Causes Amenorrhea
Risperidone causes menstrual periods to STOP (amenorrhea), not start. This occurs through drug-induced hyperprolactinemia, which disrupts normal menstrual function 1.
Mechanism and Prevalence
Risperidone is one of the most potent antipsychotics for causing hyperprolactinemia, with 50-100% of patients developing elevated prolactin levels 1. The mechanism involves dopamine D2 receptor antagonism in the hypothalamus, which removes the normal inhibition of prolactin secretion 1.
Clinical Impact on Menstruation
Women on risperidone commonly develop menstrual dysfunction:
- 37.9% experience menstrual dysfunction during maintenance treatment 2
- At baseline (after 4-8 weeks of treatment), 26.8% already have menstrual problems: irregular menstruation (14.3%), oligomenorrhea (6.8%), or amenorrhea (5.0%) 2
- Among those with normal periods initially, 16% develop menstrual dysfunction during continued treatment 2
- Approximately 70% of patients with menstrual disorders were receiving risperidone in one study 3
Timeline and Dose Relationship
Menstrual dysfunction can occur early or late during treatment:
- Onset ranges from 64 to 243 days after starting risperidone 2
- Dose-dependent effect: Higher risperidone doses correlate with increased menstrual dysfunction (r = 0.187, P = 0.046) 2
- Prolactin levels above 60 ng/mL are the optimal cutoff for predicting menstrual disorders 3
- Mean prolactin levels in patients with menstrual disorders: approximately 90 ng/mL (2-fold higher than those without menstrual problems) 3
Management Algorithm
If amenorrhea develops on risperidone:
Measure serum prolactin level to confirm hyperprolactinemia 1
Most effective strategy: Switch to prolactin-sparing antipsychotic (olanzapine, quetiapine, aripiprazole)—this results in menstrual recovery in all patients 4
Alternative: Discontinue risperidone (if clinically feasible)—menstruation resumes in patients who stop the medication 4, 5
Least effective: Dose reduction—rarely successful because:
Critical Caveats
Do not discontinue or substitute antipsychotics without consulting the prescribing psychiatrist 1. The psychiatric stability must be weighed against endocrine side effects.
If hyperprolactinemia onset does not coincide with therapy initiation, obtain pituitary MRI to rule out prolactinoma or other pituitary/hypothalamic masses 1.
Long-term consequences of untreated hyperprolactinemia include:
- Hypogonadism with associated symptoms
- Increased risk of bone loss and osteoporosis 1
- Cardiovascular disease risk 6
- Psychological distress 6
For asymptomatic medication-induced hyperprolactinemia, no treatment is necessary 1. However, if hypogonadal symptoms or low bone mass develop, consider estrogen or testosterone replacement 1.